Tiragolumab(RG6058/MTIG7192A) 10mg

Tiragolumab(RG6058/MTIG7192A) 10mg

Brand: RCpeptides
4500.00 EUR In stock Buy at Merchant

Tiragolumab is a monoclonal antibody used to enhance anti-tumor immunity, typically in combination with PD-L1 blockade.

  • The description claims that Tiragolumab is investigational and not FDA/EMA-approved.
  • The description claims that Tiragolumab received FDA Breakthrough Therapy Designation for PD-L1-high metastatic NSCLC in combination with atezolizumab.
Variants (1)
  • Default Title — 4500.00 EUR — In stock

How AI sees this product

The more complete this product's details, the more confidently AI assistants can understand and recommend it.

66%
4 details missing that AI looks for Claim to see how to fix it
Data sourced from rcpeptides.com. Last updated: This description was written with AI from the merchant's product information, so some details may vary.
Claim rcpeptides.com to control what AI sees, no website changes

Takes ~2 minutes. No changes to your website.